Indication

Duodenal ulcer due to H. pylori

Duodenal ulcer due to *H. Read more about Duodenal ulcer due to H. pylori

302 drugs 136 manufacturers

Advertisement

Drugs that treat it

Common Duodenal ulcer due to H. pylori therapies.

Showing 235–243 of 302 drugs

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
RISING PHARM

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
AUROBINDO PHARM

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
NUCARE PHARMACE

OMEPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
NUCARE PHARMACE

OMEPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
BLUEPOINT LABOR

OMEPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
PREFERRED PHARM
Filter & compare in the drug finder →Opens the drug finder with Duodenal ulcer due to H. pylori preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Duodenal ulcer due to H. pylori.

Duodenal ulcer due to *H.

pylori* is a peptic ulcer disease characterized by a distinct mucosal break extending into the muscularis propria within the proximal small intestine, specifically triggered by *Helicobacter pylori* infection.

Primarily affecting adults within the gastrointestinal system, the infection typically induces antral-predominant gastritis, hypergastrinemia, and gastric acid hypersecretion that overwhelms normal duodenal mucosal defenses and bicarbonate secretion.

Clinically, it manifests as burning epigastric pain that frequently occurs between meals or at night and improves with food intake or antacids.

If untreated, the condition can progress to serious gastrointestinal complications, including acute hemorrhage, luminal obstruction, or perforation.

Personalize your experience

Follow Duodenal ulcer due to H. pylori and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it